News and Events

WHEN: Wednesday, April 16, 1pm

WHERE: North Campus Research Complex (NCRC) Building 18 Dining Hall


Download and print directions [pdf] and/or a map.

Translational Oncology Program Special Seminar

Clifton Leaf will present: "Change from within: Why the cancer research enterprise needs a transformation, and how we can acheive it."

Help spread the word! Download and print the Translational Oncology Program Special Seminar event flyer [pdf]

About Clifton Leaf
Clifton Leaf, an assistant managing editor at Fortune magazine, is the author of The Truth in Small Doses: Why We're Losing the War on Cancer-and How to Win It, published by Simon & Schuster last summer. A winner of the Gerald Loeb Award for Distinguished Business and Financial Journalism and a two-time finalist for the National Magazine Award, Cliff was until recently a guest editor for The New York Times op-ed page and Sunday Review. Previously, he was executive editor at The Wall Street Journal's SmartMoney magazine and, prior to that, executive editor at Fortune, where he also wrote a number of prominent feature articles.

It was after one such writing assignment, a 2004 Fortune cover story entitled "Why We're Losing the War on Cancer (and How to Win It)," that Cliff began working to change the way the global cancer fight is funded and pursued, pushing for ways to speed up progress against the disease. A keynote or featured speaker at some 30 scientific conferences around the world, Cliff has presented testimony to the President's Cancer Panel three times, given a plenary address at the annual meeting of the American Association for Cancer Research and delivered "Grand Rounds" at the National Cancer Institute.

A recipient of the Henry R. Luce Award for public service, the NIHCM's Health Care Journalism Award and several leadership awards from patient organizations, Cliff has been a moderator or panelist in numerous cancer-related meetings, including three Capitol Hill briefings for members of Congress. For three years, he also served on the national board of directors for Susan G. Komen for the Cure, the world's largest breast cancer charity.

Prior to joining Fortune in 2000, Cliff was an editor and writer for a number of national magazines. A graduate of Williams College, he later received a Master of Fine Arts in writing from Sarah Lawrence College. He lives in Brooklyn, New York.

Save The Date: June 7!

Find out how researchers at the University of Michigan are getting one day closer to a cure for cancer.

On Saturday, June 7, 2014 the scientists of the University of Michigan Translational Oncology Program (TOP) will be coming into their labs to move us one day closer for a cure. They invite you to come out and meet them, hear about their research - and discoveries, tour and participate in interactive lab stations.

“We cannot cure cancer in one day, but each day of research brings us one day closer to a cure." - Ashley Harris, TOP Scientist

Register using our online form!

One Day Closer
Saturday, June 7, 2014
10 a.m. - 2 p.m.
TOP Laboratories
University of Michigan
North Campus Research Complex
1600 Huron Parkway, Building 520

We would like to recognize our sponsors for supporting this event with supplies and donations:
Fisher Scientific, Denville Scientific, Corning and Atlas Biologicals.

For more information or to help spread the word, please download and print the One Day Closer event flyer.


Current Headlines

Drs. Petros Grivas, Mark Day, Maha Hussain
from left to right: Drs. Petros Grivas, Mark Day and Maha Hussain
Bladder cancer is a common cancer that can be fatal and has not benefited from therapeutic advances over two decades. Researchers at the University of Michigan Translational Oncology Program (T.O.P) were able to generate important preclinical data demonstrating the significant activity of a next-generation compound in human models of bladder cancer. This compound, which is also being tested in patients with lung cancer, inhibits biologic pathways that are considered involved in the development and progression of bladder cancer. The data, recently published at "Molecular Medicine" by Drs. Petros Grivas, Maha Hussain, Mark Day and several colleagues, have supported the design of a clinical trial that aims to evaluate the safety of this compound in combination with chemotherapy (gemcitabine/cisplatin) in patients with advanced bladder cancer. This will be the first trial to assess the activity of this inhibitor in patients with this disease, and evaluate its combination with this specific chemotherapy regimen in humans. This is a characteristic example of the mission, vision and goals of the T.O.P., which was created to effectively bridge the gap between the laboratory and the clinic leading to better treatments for the cancer patient.

Links to news articles, videos and radio interviews about the Translational Oncology Research Program (TOP)

Video

Diane Simeone, MD, Lazar J. Greenfield Professor of Surgery and Professor of Molecular & Integrative Physiology and Chief, Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at the University of Michigan gives an overview of pancreatic cancergoing to a new website including treatment research in the area of stem cells, presented at the AACR 2012 Annual Meeting in Chicago.

This video presentation is also available thanks to OncologyTube.com: http://www.oncologytube.com/index.php?page=videos§ion=view&vid_id=102669

Cancer Stem Cells - Max Wicha, MDgoing to a new website
Max Wicha, MD, Director of the University of Michigan Comprehensive Cancer Center discusses cancer stem cell research

The Future of Pancreatic Cancer Treatmentgoing to a new website
Dr. Simeone's appearance on the Dr. Oz show (article with video).

Cancer stem cells: New frontier in cancer researchgoing to a new website
Taubman Institute Health Science Lecture Series. March 2013.

Cancer Stem Cell Research Introduction
from mcancer.org, cancer stem cell tutorial with video.

Innovative Researcher Profile: Dr. Elizabeth R. Lawlorgoing to a new website
Elizabeth R. Lawlor, MD, PhD, Associate Professor, Department of Pathology and Associate Professor, Department of Pediatrics and Communicable Diseases is profiled on the Stand Up to Cancer YouTube channel.

Radio

Curelaunchers and Meals to Healgoing to a new website
Stupid Cancer Show: The voice of young adult cancer. BlogTalkRadio.com. 21 January 2013.

from WIBW.com:
An article with radio interview featuring the work of Mark S. Cohen, M.D., Associate Professor of Surgery and Director of Endocrine Surgery Research: Plant-Based Molecules Show Cancer-Fighting Potentialgoing to a new website

Rob Stein. Lab Findings Support Provocative Theory On Cancer 'Enemy' Withingoing to a new website
All Things Considered, National Public Radio. 01 August 2012 (article and radio interview).

News Articles

Tomatillo plant shows promise in cancer treatment
LJWorld.com

Researchers hope prairie's wild tomatillo may provide medical breakthrough in cancer fightgoing to a new website
Witchita Eagle Kansas.com

Tomatillo: Cancer-fighting potential?going to a new website
Topeka Capital-Journal cjonline.com

Compounds in the Wild Tomatillo Weed May Combat Cancergoing to a new website
Indian Country Today Media Network

Dr. Elizabeth Lawlor, M.D. Ph.D. � University of Michigangoing to a new website
Go4theGoal

Grant Awarded to Scientist Investigating Cancerous Cell Survival in Childrengoing to a new website
CureSearchforChildren'sCancer

News Articles from University of Michigan publications

U-M Cancer Center gets $28.4 million grant from NCI
mcancer.org website. 31 October, 2012.

NCRC Momentum Website Octobergoing to a new website

Diane Simeone to head translational oncology program at NCRCgoing to a new website

Speeding Promising Discoveries to Clinical Trialsgoing to a new website

Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment

Translational oncology establishes presence at NCRC: Dr. Max Wicha and researchers move their labsgoing to a new website

Return to top